aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

by | Aug 3, 2026 | Clinical Trials | 0 comments

​ Conditions: Angina With Non-Obstructive Coronary Artery Disease; Coronary Microvascular Dysfunction (CMD)

Interventions: Drug: Dapagliflozin (10mg Tab); Drug: Placebo ( FE)

Sponsors: The Christ Hospital

Not yet recruiting Conditions: Angina With Non-Obstructive Coronary Artery Disease; Coronary Microvascular Dysfunction (CMD)
Interventions: Drug: Dapagliflozin (10mg Tab); Drug: Placebo ( FE)
Sponsors: The Christ Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *